–
C4 Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−82.1
FY22:
−130
FY23:
−139
FY24:
−120
FY25:
−115
(positive)
Change from FY21 to FY23
millions USD
FY21:
−80.3
FY22:
−124
FY23:
−127
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−83.9
FY22:
−128
FY23:
−131
FY24:
−105
FY25:
−105
(positive)
Change from FY21 to FY25
millions USD
FY21:
−83.9
FY22:
−128
FY23:
−132
FY24:
−105
FY25:
−105
All amounts in millions USD